Skip to main content
Journal cover image

GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.

Publication ,  Journal Article
Gurbel, PA; Tantry, US
Published in: Lancet
May 6, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

May 6, 2017

Volume

389

Issue

10081

Start / End Page

1773 / 1775

Location

England

Related Subject Headings

  • Rivaroxaban
  • Platelet Aggregation Inhibitors
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Aspirin
  • Acute Coronary Syndrome
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2017). GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes. Lancet, 389(10081), 1773–1775. https://doi.org/10.1016/S0140-6736(17)30760-2
Gurbel, Paul A., and Udaya S. Tantry. “GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.Lancet 389, no. 10081 (May 6, 2017): 1773–75. https://doi.org/10.1016/S0140-6736(17)30760-2.
Gurbel, Paul A., and Udaya S. Tantry. “GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.Lancet, vol. 389, no. 10081, May 2017, pp. 1773–75. Pubmed, doi:10.1016/S0140-6736(17)30760-2.
Journal cover image

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

May 6, 2017

Volume

389

Issue

10081

Start / End Page

1773 / 1775

Location

England

Related Subject Headings

  • Rivaroxaban
  • Platelet Aggregation Inhibitors
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Aspirin
  • Acute Coronary Syndrome
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences